000 01511 a2200421 4500
005 20250518001331.0
264 0 _c20200921
008 202009s 0 0 eng d
022 _a1365-2133
024 7 _a10.1111/bjd.17253
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWeon, J L
245 0 0 _aNovel therapeutic approaches to xeroderma pigmentosum.
_h[electronic resource]
260 _bThe British journal of dermatology
_c08 2019
300 _a249-255 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAcetohexamide
_xpharmacology
650 0 4 _aAdministration, Cutaneous
650 0 4 _aAnimals
650 0 4 _aCaloric Restriction
650 0 4 _aDNA Damage
_xdrug effects
650 0 4 _aDNA Repair
_xdrug effects
650 0 4 _aDermatology
_xmethods
650 0 4 _aDisease Models, Animal
650 0 4 _aHumans
650 0 4 _aNiacinamide
_xpharmacology
650 0 4 _aProtective Clothing
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aSulfonylurea Compounds
_xpharmacology
650 0 4 _aSunlight
_xadverse effects
650 0 4 _aSunscreening Agents
_xadministration & dosage
650 0 4 _aTreatment Outcome
650 0 4 _aUltraviolet Rays
_xadverse effects
650 0 4 _aXeroderma Pigmentosum
_xgenetics
700 1 _aGlass, D A
773 0 _tThe British journal of dermatology
_gvol. 181
_gno. 2
_gp. 249-255
856 4 0 _uhttps://doi.org/10.1111/bjd.17253
_zAvailable from publisher's website
999 _c28884736
_d28884736